Morocco latest patents query

The latest invention patents collect the data information of Morocco invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.

ANTI-PD-L1 ANTIBODY TREATMENT FOR BLADDER CANCER

UndeterminedMA47509A
Owner:MEDIMMUNE LLC

NETWORK ARCHITECTURE, PROCESSES AND DEVICES FOR A WIRELESS COMMUNICATION NETWORK

UndeterminedMA45952A
Owner:TELEFONAKTIEBOLAGET LM ERICSSON (PUBL)

FUNCTIONAL ELEMENT WITH ELECTRICALLY CONTROLLABLE OPTICAL PROPERTIES

UndeterminedMA52744A
Owner:SAINT GOBAIN VITRAGE SA

ANTI-ALPHA-SYNUCLEIN ANTIBODIES

UndeterminedMA51134A
Owner:UCB BIOPHARMA SPRL

MIXING AND PROCESSING APPARATUS AND METHOD

UndeterminedMA43867A
Owner:ALKYMAR

CLIP-ON BOTTLE MOLD

InactiveMA39976A
Owner:BTC CONCEPT

METHOD FOR TREATMENT OF ACUTE KIDNEY INJURY

InactiveMA46459ALower Level Requirementsimprove kidney function
Owner:MITOBRIDGE INC

VACUUM DEPOSIT INSTALLATION AND SUBSTRATE COATING METHOD

UndeterminedMA52864A
Owner:ARCELORMITTAL SA

LSD1 INHIBITORS AND THEIR MEDICAL USES

ActiveMA46625A
Owner:CONSTELLATION PHARMA INC

SPIROTHIETNAMESE NUCLEOSIDES

UndeterminedMA50025A
Owner:JANSSEN PHARMA NV

BRUTON TYROSINE KINASE CRYSTAL POLYMORPHS

UndeterminedMA53914A
Owner:BIOGEN MA INC

STABLE ANTIBODY FORMULATION

InactiveMA49043A
Owner:REGENERON PHARMACEUTICALS INC

DIPPING BLOCK, DIRECT COOLING PLATE AND BATTERY MODULE

UndeterminedMA71653A
Owner:EVE POWER CO LTD

VACUUM MIXER

UndeterminedMA47470A
Owner:TROJAN R JOSEPH

C5AR TARGETING ANTIBODIES

UndeterminedMA55285A
Owner:MORFOZIS AG

SYSTEM AND METHOD FOR TRACING A PRODUCT ITEM

UndeterminedMA48586A
Owner:SICPA HOLDING SA

BICYCLIC HISTONE DEACETYLASE INHIBITORS

UndeterminedMA47305A
Owner:RODIN THERAPEUTICS INC

POWDER FOR MOLD AND MOLD COATING

UndeterminedMA54291A
Owner:ELKEM

TRANSDIFFERENTIATED TISSUE GRAFTS

UndeterminedMA40341A
Owner:EDER CLAUDIA +1

A method for producing a high strength steel piece

ActiveMA40200A
Owner:ARCELORMITTAL SA

MAGL INHIBITORS

UndeterminedMA46855A
Owner:H LUNDBECK AS

Powdered emulsion for animal feed

UndeterminedMA40433A
Owner:SEVECOM SPA

OPTOELECTRONIC COMPONENT

UndeterminedMA45817A
Owner:AIT AUSTRIAN INSTITUTE OF TECNOLOGY GMBH

BENZOTHIAZOLES AND RELATED COMPOUNDS

UndeterminedMA49766A
Owner:SPINOGENIX INC

AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS

UndeterminedMA40587A
Owner:PFIZER INC

COMPOSITIONS CONTAINING BACTERIAL STRAINS

InactiveMA41104Agreat tastemore
Owner:4D PHARMA RES LTD

NEW COMPOUNDS

UndeterminedMA44050A
Owner:MISSION THERAPEUTICS LTD

Benzoxabolol compounds and their uses

UndeterminedMA41495A
Owner:ANACOR PHARMACEUTICALS LLC +1

MICROORGANISM THAT PRODUCES HUMAN MILK OLIGOSACCHARIDE

UndeterminedMA51454A
Owner:OLIGOSCI BIOTECH GMBH

BETA-SECRETASE INHIBITORS

UndeterminedMA47731A
Owner:JANSSEN PHARMA NV

CONTROL CHANNEL STRUCTURE DESIGN TO SUPPORT V2X TRAFFIC

UndeterminedMA51604A
Owner:NOKIA TECHNOLOGIES OY

ORAL CARE COMPOSITION CONTAINING CANNABINOIDS

UndeterminedMA41212A
Owner:APIRX PHARMACEUTICAL USA LLC

Lyophilized factor ix formulations

UndeterminedMA39779A
Owner:BIOGEN MA INC

SEMAGLUTIDE USED IN THE TREATMENT OF CARDIOVASCULAR DISEASES

UndeterminedMA44762A
Owner:NOVO NORDISK AS

Heparan sulfate biosynthesis inhibitors for treating diseases

UndeterminedMA40957A
Owner:BIOMARIN PHARMACEUTICAL INC

USE OF LECITHINS AS A BIOCIDE AGAINST ARTHROPODS

UndeterminedMA51607A
Owner:ORTEGA CARRASCO JAVIER CARLOS +1

Swing-and-slide door module with a central function connection

UndeterminedMA40166A
Owner:KNORR BREMSE GMBH

ELECTRODE AND ELECTROCHEMICAL CELL

UndeterminedMA71458A
Owner:CERES INTELLECTUAL PROPERTY COMPANY LIMITED

Construction panel with improved fixing strength

UndeterminedMA40977A
Owner:SAINT GOBAIN PLACO SAS

Anti-il4-il 13 bispecific antibodies

UndeterminedMA40164A
Owner:SANOFI SA(FR)

Cenicriviroc for the treatment of hiv-2 infection

UndeterminedMA39991A
Owner:TOBIRA THERAPEUTICS INC

2-OXO-1-PYRROLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES

UndeterminedMA51126A
Owner:UCB BIOPHARMA SPRL

Dantrolene Promedicines and Their Methods of Use

UndeterminedMA50403A
Owner:EAGLE RES LABS LTD

MACROCYCLICAL COMPOUNDS USED AS STING AGONISTS

UndeterminedMA55517A
Owner:LUPIN LTD

HEATED VEHICLE WINDOW WITH TRANSPONDER

UndeterminedMA56498A
Owner:SAINT GOBAIN VITRAGE SA

ELECTRICAL CONNECTION ELEMENT

ActiveMA45215A
Owner:LEGRAND FRANCE SA +1

COMPOSITION AND ITS USE IN AN EMULSION OR IN A FOOD PRODUCT

UndeterminedMA54908A
Owner:INT N&H DENMARK APS

PD-L1 ANTIBODIES AND THEIR USE

UndeterminedMA50038A
Owner:R PHARM OVERSEAS INC

MOLDING STATION FOR SHEAR CORE PRODUCTION AND ITS MANUFACTURING PROCESS

UndeterminedMA52139A
Owner:LM WIND POWER INT TECH II APS

ALTERNATIVE TO NATURAL COCOA AND ITS PRODUCTION PROCESSES

UndeterminedMA46207A
Owner:INTERNATIONAL AGRICULTURE GROUP LLC

PREPARATION SLEDGE AND ASSEMBLY METHOD FOR A VEHICLE

UndeterminedMA48979A
Owner:PSA AUTOMOBILES SA

RNA VACCINES AGAINST THE ZIKA VIRUS

UndeterminedMA50253A
Owner:MODERNATX INC

ANTI-LAG-3 ANTIBODIES AND THEIR METHODS OF USE

UndeterminedMA46529A
Owner:AGENUS INC

ANTI-GITR ANTIBODIES AND THEIR METHODS OF USE

ActiveMA40041AHigh expression
Owner:MEMORIAL SLOAN KETTERING CANCER CENT +2

METHOD PROVIDING ORAL CARE BENEFITS

UndeterminedMA46822A
Owner:FERTIN PHARMA AS +1

SYSTEMS FOR THE DETECTION OF SUBTISSUE ABNORMALITIES

UndeterminedMA39921A
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST

Stylus winding device for winding surgical threads

UndeterminedMA41971A
Owner:ETHICON INC

Covalent BTK inhibitors and their uses

UndeterminedMA44789A
Owner:X CHEM

MODIFICATION OF RNA-RELATED ENZYMES FOR IMPROVED PRODUCTION

UndeterminedMA56219A
Owner:TRANSLATE BIO INC

SLIDING SUSPENSION SYSTEM

UndeterminedMA52600A
Owner:SAUDI ARABIAN OIL CO

METHOD FOR MANUFACTURING A STAMPED CONCRETE ELEMENT

UndeterminedMA48725A
Owner:METTEN STEIN DESIGN GMBH & CO KG +1

Cyclic dinucleotides useful for treating, among other things, cancer

UndeterminedMA41415A
Owner:GLAXOSMITHKLINE INTPROP DEV LTD

ARRANGEMENT FOR ATTACHING A TRAILER TO A DEPLOYMENT DEVICE

UndeterminedMA43820A
Owner:THYBOROEN SKIBSSMEDIE

PROCESSES FOR PRODUCING ANTI-TNF ANTIBODY COMPOSITIONS

UndeterminedMA55284A
Owner:JANSSEN BIOTECH INC

THERAPEUTIC AGENT AGAINST FIBROSIS

UndeterminedMA42266A
Owner:TAIHO PHARMA CO LTD

PIPE EQUIPPED WITH A DETECTION ELEMENT

ActiveMA41549A
Owner:PLYMOUTH FRANCAISE SA +1

METHODS OF TREATMENT FOR FEMALE INFERTILITY

UndeterminedMA46353A
Owner:MYOVANT SCIENCES GMBH

METHOD FOR GENERING MODIFIED CELL THERAPEUTIC COMPOSITIONS

UndeterminedMA50855A
Owner:JUNO THERAPEUTICS INC

METHOD FOR CONTROLLING ACCESS TO A MOTOR VEHICLE

UndeterminedMA45497A
Owner:HUF HÜLSBECK & FÜRST GMBH & CO KG

Edible composition based on soy and sunflower oil

UndeterminedMA41162A
Owner:VALSOIA

Refractory binder system

UndeterminedMA40002A
Owner:VESUVIUS CRUCIBLE CO

Greenhouse screen

InactiveMA49619Amilder climatereduce manufacturing cost
Owner:AB LYUDVIG SVENSSON

ADENOVIRUS AND RELATED USES

UndeterminedMA50502A
Owner:JANSSEN VACCINES & PREVENTION BV

NUCLEAR TRANSPORT MODULATORS AND THEIR USES

UndeterminedMA43530A
Owner:KARYOPHARM THERAPEUTICS INC

IMPLANTABLE ENDOLUMINAL PROSTHESIS

UndeterminedMA43223A
Owner:CARDIATIS SA +1

Gene therapy to treat type I mucopolysaccharidosis

UndeterminedMA43968A
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

BUSE MULTILIQUIDE

UndeterminedMA49445A
Owner:INVOX BELGIUM NV

TRIARYL COMPOUNDS FOR THE TREATMENT OF PD-L1 DISEASES

UndeterminedMA55974A
Owner:CHEMOCENTRYX INC

COMPOSED WITH ANTIMICROBIAL ACTIVITY

UndeterminedMA52229A
Owner:OFFHEALTH SPA

OBITECRAPIB SALTS AND THEIR MANUFACTURING PROCESS AND INTERMEDIARIES

UndeterminedMA71399A
Owner:NEWAMSTERDAM PHARMA BV

MODIFIED DNA-BINDING PROTEINS

UndeterminedMA50942A
Owner:ENCODED THERAPEUTICS INC

WATER-BASED PHARMACEUTICAL FORMULATIONS OF 1,2-DIHYDROPYRIDINE COMPOUNDS

UndeterminedMA54460A
Owner:EISAI R&D MANAGEMENT CO LTD

COMMUNICATION DEVICE, METHOD AND COMPUTER PROGRAM

ActiveMA49423A
Owner:NOKIA TECHNOLOGIES OY

COMBINATION THERAPIES WITH SERIBANTUMAB

UndeterminedMA45420A
Owner:MERRIMACK PHARMACEUTICALS INC

ROR-GAMMA MODULATORS

UndeterminedMA55328A
Owner:VITAE PHARMA INC

GLYT1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS

ActiveMA39927A
Owner:F HOFFMANN LA ROCHE & CO AG

AERODYNAMIC BLADE POWERED BY AN ENERGY STORAGE DEVICE

UndeterminedMA48985A
Owner:COMPAGNIE PLASTIC OMNIUM SA

COMPOSITIONS CONTAINING BACTERIAL STRAINS

InactiveMA41013Agreat tastemore
Owner:4D PHARMA RES LTD

ICOS BINDING PROTEINS

UndeterminedMA47386A
Owner:CENT NAT DE LA RECH SCI (C N R S) +4

CONTINUOUS SOLAR DISTILLER WITH EFFICIENT HEAT RECOVERY

UndeterminedMA53233A
Owner:WATERTRANSFORMER GMBH

IL-15 INHIBITORS USEFUL FOR THE TREATMENT OF ATOPIC DERMATITIS

UndeterminedMA71681A
Owner:NOVARTIS PHARMA AG

METHODS FOR MANUFACTURING MODIFIED BTK INHIBITORS

UndeterminedMA71245A
Owner:PRINCIPIA BIOPHARMA INC

NEW NRF2 PATHWAY ACTIVATING COMPOUNDS

UndeterminedMA49828A
Owner:ALMIRALL SA